Management of the metabolic syndrome-nicotinic acid.
Nicotinic acid effectively treats each of the common lipid abnormalities found in the metabolic syndrome, and much progress has recently been made in understanding its mechanisms of action. Early concern that nicotinic acid can precipitate or worsen diabetes has been eased with recent trials, which demonstrated its safety and effectiveness in insulin-resistant states. Furthermore, nicotinic acid prevents cardiovascular disease and death in persons with a high prevalence of risk factors for the metabolic syndrome. When used by an experienced physician and taken by a motivated patient, nicotinic acid can be safe and effective in treating the dyslipidemia of the metabolic syndrome.
Meyers
C Daniel
CD
Atherosclerosis Research Center, VA Long Beach Healthcare System, 5901 East 7th Street (11-111I), Long Beach, CA 90822, USA.
Kashyap
Moti L
ML
D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000188:drug therapy*; D009525:Niacin / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D009525:Niacin